Lupin Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Mid Cap

Turqoz (Norgestrel and Ethinyl Estradiol) tablets are the generic equivalent of Lo/Ovral-28 (Norgestrel and Ethinyl Estradiol) tablets of Wyeth Pharmaceuticals LLC and is a contraceptive drug indicated to prevent pregnancy.

According to IQVIA MAT October 2023, Norgestrel and Ethinyl Estradiol tablets (RLD: Lo/Ovral-28) had estimated annual sales of $33 million in the U.S.

Lupin is a leading manufacturer of active pharmaceutical ingredients (APIs) in India and a key supplier to global bodies and governments in more than 70 countries.

The pharmaceutical company’s consolidated net profit zoomed to Rs 495.32 crore in Q2 FY24 as against Rs 134.47 crore recorded in Q2 FY23. Revenue from operations rose 20.7% YoY to Rs 4,939.23 crore in Q2 FY24.

The srip declined 2.36% to currently trade at Rs 1,265.75 on the BSE.

Powered by Capital Market - Live News

Lupin announced the launch of Turqoz® (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg, after having received an approval from the United States Food and Drug Administration (U.S. FDA).

Turqoz® (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg is the generic equivalent of Lo/Ovral-28 (Norgestrel and Ethinyl Estradiol) Tablets, 0.3 mg/0.03 mg of Wyeth Pharmaceuticals LLC and is a contraceptive drug indicated to prevent pregnancy.

Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of USD 33 million in the U.S. (IQVIA MAT October 2023).

Powered by Capital Market - Live News

Lupin Ltd is up for a fifth straight session today. The stock is quoting at Rs 1296.1, up 1.19% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.72% on the day, quoting at 20277.3. The Sensex is at 67498.57, up 0.76%. Lupin Ltd has gained around 10.85% in last one month.

Meanwhile, Nifty Pharma index of which Lupin Ltd is a constituent, has gained around 9.79% in last one month and is currently quoting at 16238.9, up 0.3% on the day. The volume in the stock stood at 6.53 lakh shares today, compared to the daily average of 15.84 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1305.2, up 1.37% on the day. Lupin Ltd is up 67.02% in last one year as compared to a 8.46% jump in NIFTY and a 24.45% jump in the Nifty Pharma index.

The PE of the stock is 49.21 based on TTM earnings ending September 23.

Powered by Capital Market - Live News

Lupin has allotted 21,390 fully paid-up equity shares of Rs 2 each under ESOP. With this allotment, the paid up equity share capital has increased to Rs 91,05,76,916 consisting of 45,52,88,458 equity shares of Rs 2/- each.

Powered by Capital Market - Live News